• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problems Migration or Expulsion of Device (1395); Improper Flow or Infusion (2954); Infusion or Flow Problem (2964); Positioning Problem (3009)
Patient Problem Insufficient Information (4580)
Event Type  Injury  
Event Description
Information was received form a healthcare provider via a company representative regarding a patient receiving dialudid 0.2mg/ml at 0.44997mg/day and bupivacaine 7mg/ml at 15.7490mg/day via an implantable pump.It was reported that the volume was different then the expected at refill and loss of therapy effectiveness.There were no environmental, external or patient factors that may have led or contributed to the issue disclosed to the reporter.The diagnostics and troubleshooting performed was pumpogram was performed 01-jul-2022 by the physician demonstrating epidural locations of the distal catheter tip.The actions and interventions taken to resolve the issue was catheter revision surgery to be scheduled to place the catheter in the intrathecal space.The pump infusion rate set to minimum rate of 0.00961mg/ day.Surgical intervention did not occur but was planned.The issue was not resolved at the time of the report and it was noted that the healthcare provider would not have any further information regarding the event.
 
Manufacturer Narrative
Concomitant medical products: product id: 8780, serial#: (b)(4), implanted: (b)(6) 2021, product type catheter.Other relevant device(s) are: product id: 8780, serial/lot #: (b)(4), ubd: 17-dec-2022, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from the healthcare provider (hcp) via a company representative reported that a dye study was attempted on (b)(6) 2022 but the hcp was unsuccessful in aspirating the catheter, so the dye study was not completed.It was also indicated that the catheter had been placed in the epidural space by the hcp.There were no external factors that may have contributed to the issue.Surgery occurred today to revise the catheter.The catheter was explanted and replaced with new catheter in intrathecal space.Cerebrospinal fluid (csf) flow was observed at the placement of new catheter.The event was resolved.
 
Manufacturer Narrative
Continuation of d10: product id 8780 serial# (b)(6) implanted: (b)(6) 2021 product type catheter.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key14975112
MDR Text Key295600608
Report Number3004209178-2022-08689
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00643169630512
UDI-Public00643169630512
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/11/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/28/2022
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/18/2022
Date Device Manufactured01/29/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
"SEE H10...."
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-